From: Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience
NAC (n = 89)
Non-NAC (n = 78)
p value
AGE (years)
60 (30–79)
65 (37–82)
P < 0.01
SEX
Male
70
69
0.09
Female
19
9
STAGE
I
3
0.92
IIA
20
16
IIB
6
III
50
44
IV
10
TYPE
Adenocarcinoma
0.23
Squamous Cell Carcinoma
67
11